Investment Banking

Recent News

  • Jul 12, 2010
    Caris & Company promotes Craig A. Ellis to Director...
    Read More
  • Jun 14, 2010
    Caris & Company appoints Jamie Ryan Pennington...
    Read More
  • May 28, 2010
    Caris & Company acts as Underwriter in Salix Pharmaceuticals...
    Read More
  • May 10, 2010
    Caris & Company appoints Sandeep Aggarwal Managing...
    Read More

Recent Transactions

Caris & Company is proud to announce participation in the following transactions:


  1. $345,000,000

    Salix

    Convertible Senior Notes

    Co-Manager

    May 27th, 2010

  2. $19,200,000

    Adventrx

    Registered Direct

    Financial Advisor

    May 3rd, 2010

  3. $91,547,730

    Alpha & Omega Semiconductor

    Initial Public Offering

    Co-Manager

    April 29th, 2010

  4. $195,443,286

    NetLogic

    Follow-On Offering

    Selling Group Participant

    March 25th, 2010

  5. $149,000,000

    Syntiron

    Licensing Advisory

    December 16th, 2009

  6. $13,200,000

    Wilex

    Private Placement

    Joint Lead Manager

    December 3rd, 2009

  7. $5,500,000

    PharmAthene

    Registered Direct

    Co-placement Agent

    March 24th, 2009

  8. $160,000,000

    Healthcare Technology

    M&A Buy Side

    Advisor

    February 15th, 2009

  9. $45,000,000

    Healthcare Technology

    M&A Buy Side

    Advisor

    November 15th, 2008

  10. $50,000,000

    Medical Diagnostics

    M&A Sell Side

    Advisor

    August 15th, 2008

  11. $12,500,000

    Underground Solutions

    Common Stock

    Financial Advisor

    December 17th, 2007

  12. $21,000,000

    Response Genetics

    IPO

    Co-Manager

    June 5th, 2007

  13. $96,427,500

    Omnicell

    Common Stock

    Co-Manager

    May 22nd, 2007

  14. $17,000,000

    ResVerlogix

    Senior Secured Convertible Notes

    Co-Manager

    January 5th, 2007

  15. $10,000,000

    Cardax

    Series B Preferred Stock

    January 1st, 2007

  16. $56,940,000

    Nextest

    Common Stock

    Initial Public Offering

    March 21st, 2006

  17. $24,000,000

    SGX

    Common Stock

    Initial Public Offering

    January 31st, 2006

  18. $567,168,000

    Spansion

    Common Stock

    Initial Public Offering

    December 16th, 2005

  19. $21,250,000

    Vivus

    Common Stock

    Follow On Offering

    March 10th, 2005

  20. $79,350,000

    Cypress

    Common Stock

    Follow On Offering

    April 2nd, 2004

  21. $110,400,000

    Corgentech

    Common Stock

    Initial Public Offering

    February 12th, 2004

  22. $64,000,000

    Esperion Therapeutics

    Common Stock

    Follow On Offering

    July 31st, 2003